0%
Loading ...
Active Ingredients: Ceftazidime (2000 mg) and Avibactam (500 mg)
Pharmaceutical Grade Excipients: Sterile, pyrogen-free diluent (WFI – Water for Injection)
Provides broad-spectrum antibacterial activity against multidrug-resistant Gram-negative bacteria
Effective in treating complicated intra-abdominal, urinary tract, and respiratory infections
Combines a third-generation cephalosporin with a β-lactamase inhibitor for enhanced efficacy
Restores the activity of ceftazidime against resistant bacterial strains
Demonstrates excellent safety and clinical success rates
Ceftazidime and Avibactam Injection 2.5 gm is a sterile, parenteral antibacterial combination used for the treatment of severe infections caused by Gram-negative bacteria, including resistant strains producing extended-spectrum β-lactamases (ESBLs) and carbapenemases.
Ceftazidime, a third-generation cephalosporin, inhibits bacterial cell wall synthesis, while Avibactam, a non-β-lactam β-lactamase inhibitor, protects Ceftazidime from enzymatic degradation. Together, they provide potent and broad antibacterial coverage.
This combination is indicated for hospital-acquired infections, intra-abdominal infections, and urinary tract infections in adult and pediatric patients. The formulation ensures consistent plasma levels and reliable clinical efficacy when administered intravenously.
Complicated intra-abdominal infections (cIAI)
Complicated urinary tract infections (cUTI), including pyelonephritis
Hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP)
Infections caused by multidrug-resistant Enterobacteriaceae and Pseudomonas aeruginosa
Adults: 2.5 gm (Ceftazidime 2 gm + Avibactam 0.5 gm) every 8 hours, administered by intravenous infusion over 2 hours
Dosage adjustment is required for patients with renal impairment
Use under the supervision of a qualified healthcare professional only
All our products are manufactured in WHO-GMP certified facilities using state-of-the-art technology, ensuring consistent quality, precision, and safety in every batch.
We offer a range of customizable packaging formats to meet varying market and patient needs—providing long-term value for patients and healthcare providers alike.
We provide complete regulatory documentation and support to meet global standards, including FDA, EMA, and Indian compliance requirements, enabling seamless product registration and distribution.
Expand your brand with ease. We offer private label solutions so you can market our high-quality products under your own label, tailored to your branding and market strategy.
Our facilities utilize advanced propellant and valve systems to ensure the precision of each dose.
Our quality control measures ensure that every inhaler meets the highest standards for sterility
and consistency. We also focus on particle size control, ensuring optimal delivery of the
medication deep into the lungs for maximum therapeutic benefit.
Whether you’re seeking a reliable third-party manufacturing partner or exploring new product development opportunities, we’d love to hear from you.
Fill out the form below, and our expert team will get in touch within 24 hours to understand your requirements and explore how we can support your brand’s growth.
Have questions or specific needs? Reach out to us directly at parthagarwal@mayabiotechindia.com or call us at +91-9316999212. We look forward to building a long-term partnership and delivering high-quality healthcare solutions to your customers.
Corporate Office
Plot No. :46 First Floor, Industrial Area Phase-2, Chandigarh-160002, India.
Manufacturing Unit
Village Kondi, Post Thana, District Solan, Baddi 173205 Himachal Pradesh India.
